Perioperative bridging anticoagulation for atrial fibrillation-the first randomised controlled trial

James Matthew Wight, Malachy Oliver Columb, James Matthew Wight, Malachy Oliver Columb

Abstract

Abstract: Patients who have atrial fibrillation (AF) have increased thromboembolic risk. This risk is mitigated through use of anticoagulants, traditionally with vitamin K antagonists such as warfarin, and more recently with drugs such as Xa and thrombin inhibitors. Since anticoagulants increase the risk of bleeding, uncertainty exists regarding their use in the perioperative period. The risk of thromboembolism for each patient must be balanced against risk of bleeding; anticoagulation medication may be continued, replaced with a short-acting alternative or withheld entirely. Until recently, evidence on best management relied on expert opinion and observational studies. The recent publication of a randomised, double-blind, placebo-controlled trial (BRIDGE) has added important information to the knowledge base.

Trial registration: BRIDGE ClinicalTrials.gov, NCT00786474.

Keywords: Anticoagulation; Atrial fibrillation; Bleeding; Bridging; Low molecular weight heparin; Thromboembolism; Warfarin.

References

    1. Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013;368:2113–2124. doi: 10.1056/NEJMra1206531.
    1. Columb MO, Lutz JM. Bioequivalence and non-inferiority trials. Curr Anaesth Crit Care. 2009;20:98–100. doi: 10.1016/j.cacc.2009.01.001.
    1. Douketis JD, Spyropoulos AC, Spender FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:e326S–e350S. doi: 10.1378/chest.11-2298.
    1. Douketis JD, Spyropoulos AC, Scott Kaatz DO, Becker RC, Caprini JA, Dunn AS, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373:823–833. doi: 10.1056/NEJMoa1501035.
    1. Duca A, Jagoda A, Vink R, Sohne M, Huisman MV, Caldeira D, et al. Bridging anticoagulation in patients with atrial fibrillation—correspondence. N Engl J Med. 2016;374:90–94. doi: 10.1056/NEJMc1513255.
    1. Eckman MH. “Bridging on the river Kwai”: the perioperative management of anticoagulation therapy. Med Decis Making. 2005;25:370–373. doi: 10.1177/0272989X05279253.
    1. Fanning JP, Wesley AJ, Wong AA, Fraser JF. Emerging spectra of silent brain infarction. Stroke. 2014;45:3461–3471. doi: 10.1161/STROKEAHA.114.005919.
    1. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. J Am Med Assoc. 2001;285:2864–2870. doi: 10.1001/jama.285.22.2864.
    1. Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othmam M, et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med. 2008;168:63–69. doi: 10.1001/archinternmed.2007.23.
    1. Healey JS, Eikelboom J, Douketis JD, Wallentin L, Oldgren J, Yang S, et al. Periprocedural bleeding and thrombotic events with dabigatran compared with warfarin. Results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial. Circulation. 2012;126:343–348. doi: 10.1161/CIRCULATIONAHA.111.090464.
    1. Ickx BE, Steib A. Perioperative management of patients receiving vitamin K antagonists. Can J Anaesth. 2006;53(Suppl 6):S113–122. doi: 10.1007/BF03022258.
    1. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:2064–2089. doi: 10.1161/STR.0b013e318296aeca.
    1. Veitch AM, Baglin TP, Gershlick AH, Harnden SM, Tighe R, Cairns S. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut. 2008;57:1322–1329. doi: 10.1136/gut.2007.142497.
    1. Accessed 2 Feb 2016.
    1. Wysokinski WE, McBane RD, Daniels PR, Litin SC, Hodge DO, Dowling NF, et al. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc. 2008;83:639–645. doi: 10.1016/S0025-6196(11)60891-4.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera